Press releases
- Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
- GSK to share evidence supporting a personalised approach to asthma treatment at ATS 2020 Virtual
- GSK delivers Q2 sales of £7.6 billion -2% AER, -3% CER (Pro-forma -10% CER*)
Tweets from GSK US
-
GSKUS @GSKUS
Mark your calendars! GSK experts are hosting 3 #ATS2020 theatre sessions this week. Tune in for updates on #COPD maintenance therapy, severe eosinophilic #asthma and the COPD treatable traits approach. Learn more about the sessions in the ATS virtual program.👇
about 22 hours ago -
GSKUS @GSKUS
In addition to our agreement with the US Government, through our participation in the Access to #COVID19 Tools Accelerator, we continue our commitment to making our adjuvant available using mechanisms that offer fair access for people across the world. gsk.to/39J4QuT
about 4 days ago -
GSKUS @GSKUS
We’ve reached an agreement with the United States Government @HHSGov, as part of Operation #WarpSpeed to supply 100m doses of the #COVID19 vaccine candidate we’re co-developing with @sanofi. Find out more: us.gsk.com/en-us/media/pr…
about 4 days ago
